Tags : Commercialization rights

Encore Dermatology to Acquire US Commercialization Rights for Dr. Reddy’s

Shots: Encore through its subsidiary Promius Pharma, has acquired US commercialization rights for Sernivo spray (betamethasone dipropionate), Trianex (Triamcinolone Acetonide Ointment, USP) and Promiseb from Dr. Reddy The focus of the acquisition is to expand Encore’s portfolio of dermatology products for the treatment of skin diseases such as psoriasis, atopic dermatitis and acne Sernivo (betamethasone […]Read More